This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2022
Title: Shanvas Alikunju: Innovator in Dermatological Treatments
Introduction
Shanvas Alikunju is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of dermatology through his innovative approaches to treating inflammatory skin conditions. With a total of 3 patents to his name, Alikunju is recognized for his dedication to improving patient care.
Latest Patents
One of Alikunju's latest patents focuses on methods for treating inflammatory skin conditions. This application details a method of administering a pharmaceutical composition that includes a reduced dose of minocycline. The goal is to achieve an effective plasma or interstitial fluid concentration of minocycline for treating the inflammatory skin condition. This innovative approach aims to enhance treatment efficacy while minimizing potential side effects.
Career Highlights
Shanvas Alikunju is currently employed at Dr. Reddy's Laboratories, Incorporated, where he continues to develop and refine his innovative ideas. His work at this esteemed organization allows him to collaborate with other experts in the field and contribute to groundbreaking research in dermatology.
Collaborations
Some of his notable coworkers include Swati Kulkarni and Bijay Kumar Padhi. Their collaboration fosters a dynamic environment for innovation and research, further enhancing the impact of their collective work.
Conclusion
Shanvas Alikunju's contributions to dermatological treatments through his patents and work at Dr. Reddy's Laboratories highlight his commitment to advancing medical science. His innovative methods for treating inflammatory skin conditions are paving the way for improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
